Rare diseases
Investigational molecules
Locations
469 conditions with trials, the busiest first
1 123 trials across Europe, recruiting first
Study on Mesalamine to Prevent Colorectal Cancer in Patients with Lynch Syndrome
DenmarkStudy on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer
AustriaStudy on the Effects of Abiprubart for Patients with Sjögren’s Disease
CzechiaStudy on the Safety and Effectiveness of Domvanalimab, Zimberelimab, and Quemliclustat in Adults with Advanced Upper Gastrointestinal Cancer
FranceStudy of Irinotecan with S1 or 5-Fluorouracil for Patients with Metastatic Pancreatic Cancer After Gemcitabine Treatment
AustriaSafety Study of Tradipitant for Patients with Idiopathic or Diabetic Gastroparesis
BelgiumStudy on Napabucasin, Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer After Chemotherapy Failure
FranceStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
BelgiumStudy on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib
AustriaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
CroatiaThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
